Author | Elihu H. Estey, MD | OncLive

Author | Elihu H. Estey, MD


Dr. Estey Discusses the FDA Approval Process

December 18, 2013

Elihu H. Estey, MD, professor of medicine, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, discusses a potential change to the FDA approval process as it relates to Mylotarg (gemtuzumab ozogamicin).